PrednisoneVincristineCyclophosphamideGlucocorticoidsDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsProcarbazineGene DosageDosage Compensation, GeneticPrednisoloneMechlorethamineAzathioprineImmunosuppressive AgentsTreatment OutcomeDrug Administration ScheduleDrug Therapy, CombinationDosage FormsMelphalanMitoxantroneAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsMethotrexateBleomycinColor TherapyRemission InductionAdministration, OralChlorambucilLymphoma, Non-HodgkinCyclosporineMycophenolic AcidHodgkin DiseaseLymphoma, Large B-Cell, DiffuseFollow-Up StudiesAdrenal Cortex HormonesDose-Response Relationship, DrugVinblastineAsparaginaseKidney TransplantationThalidomideMultiple MyelomaTime FactorsEtoposideTacrolimusSurvival AnalysisRecurrenceGraft RejectionMethylprednisoloneDisease-Free SurvivalSurvival RateDouble-Blind MethodCombined Modality TherapyClinical Trials as TopicNephrotic SyndromeCyclosporins6-MercaptopurineProspective StudiesPolymyalgia RheumaticaRetrospective StudiesEtiocholanoloneCarmustineLymphoma, FollicularVindesinePrognosisAndrostenolsImmunosuppressionTaxoidsDrug Dosage CalculationsDexamethasoneArthritis, RheumatoidCapillary FragilityThrombocytopeniaPrecursor Cell Lymphoblastic Leukemia-LymphomaLomustineEstramustineBoronic AcidsPyrazinesGraft SurvivalRemission, SpontaneousAntirheumatic AgentsAntineoplastic Agents, HormonalProstatic NeoplasmsAntibodies, MonoclonalFluoxymesteroneOrchiectomyDacarbazine